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Polymerase Chain Reaction (PCR) was developed for a broad range of purposes. As 
part of developing a very sensitive Immuno-quantitative PCR (iqPCR) assay, we 
attempted to reproduce two of the published papers, almost always experienced false-
positive amplification. Based on personal communication from one of the authors, we 
suspected that impure reagents were responsible for the false-positive amplification. 
However, PCR can amplify a small number of DNA into enormous numbers of 
copies and the possibility of environmental contamination cannot be excluded. In this 
paper we show that our primers appeared to amplify residual DNA in the Taq DNA 
polymerase, and induced false-positive results. This finding is not in the published 
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Chapter 1: Introduction 
Immuno-PCR (IPCR) uses antibody-antigen interaction principle used in the 
Enzyme-linked immuno sorbent assay (ELISA), and obtains enormous signals 
through the PCR amplification. Instead of the enzyme, DNA is labeled to detection 
antibody, and then the labeled DNA functions as the marker. The labeled DNA is 
amplified through PCR, and IPCR’s limit of detection is theoretically 100 to 10,000 
fold better than the ELISA1, and allows for detecting even an extremely small amount 
of the target agent. However, IPCR is primary used for research purposes, because 
there is no commercial kit available for common immuno assay. 
 
In IPCR, amplicon can be measured through different techniques, such as gel 
electrophoresis. These readout techniques require additional procedures or 
experimental equipment. Among those readout techniques, Real-time PCR can 
directly measure quantification of amplicon. Immuno-quantitative PCR (iqPCR) is 




. Because there is no commercial kit for iqPCR to detect cytokines, we needed to 
develop our own iqPCR. There are different approaches to assemble the iqPCR 
detection system. We used the simplest assembling method which is a similar method 




. One of 
them used pUC19 plasmid vector, and the other used Lambda phage DNA as labeling 




them as standard sequences. We detected cytokines as antigen by using cytokines 
specific antibody with labeled DNA. After PCR, if we observed amplification of the 
labeled DNA, then it indicates we detected cytokines from the sample. Before 
immuno assay, we tested the PCR to test if it had a clean background. However, we 
found false-positive problems. This problem is common in our iqPCR because of the 
unusually large number of PCR cycles (total 70 cycles split into two rounds: 20 cycle 
in first round of PCR, and 50 cycles in second round of PCR) compared to other 
conventional PCR (usually less than 50 cycles in single round of PCR). We only 
observed the False-positive in the second round of PCR. The literature on iqPCR does 
not discuss this problem. Because of the false-positive problem, we contacted one of 
the authors and received a message about frequent contamination of Taq DNA 




PCR can amplify a single copy of a DNA sequence into millions of copy products
7
. 
Thus, contamination can be induced significant problem. To prevent environmental 
contamination, a previous study published multiple strategies to prevent 
environmental contamination
8
. In addition, contamination can come from the PCR 




















. In addition, small DNA fragments, especially smaller than 200bp, are 





Although contamination is very concerning, it has been reported related to PCR but 
not to iqPCR. The information about contamination of Taq DNA polymerase was not 
on any published papers about IqPCR, and it is a significant problem to replicate the 
result. We cannot rule out probability of environmental contamination. Because of 
that, we set out to experiment and to test where the contamination comes from, and to 
identify which small DNA fragments would be amplified through PCR. If 
contamination comes from Taq DNA polymerase, it is recommended that researchers 
should include all required and necessary information onto their papers. In addition, it 
is necessary to address that the PCR agent can possibly induce false positive 








Chapter 2: Materials and Method 
 
We purchased pUC19 (Fermantas, #SD0061, Waltham,MA) and Lambda phage DNA 
(Takara, Code 3010, Mountain View, CA) for our template. After we observed the 
false positive problem, we needed new primers for our investigation. Because of that, 
we designed new primers for the pUC19 and the Lambda phage that do not 
overlapped to previously made PCR products or previously used primers (Appendix 
A). Both of the new primers were designed to bind far downstream of the template 
DNAs, and avoid overlapping of the previously made PCR products. To prevent 
contamination from the previously used primers or previously made PCR products, 
any opened PCR materials were discarded. The entire experiment process was 
performed in 3 physically separated labs to prevent any cross contamination. PCR 
master mixes were made and commercial PCR-grade water (Ambion, #9935G, Grand 
Island, NY) was added instead of the DNA template in Lab-1. The DNA template 
was added in Lab-2, and PCR was performed in Lab-3. 1% agarose gels were made 
(Mo Bio, #15003-50, Carlsbad, CA) and run, and DNA was extracted through a 
commercial extraction kit (Promega, #328269, Madison, WI) in different work space 
in Lab-3. Each lab has its own PCR-grade water, lab coats, and pipets, thus no lab 
coats or pipets were transferred between the labs. Lab-3 contained one set of lab coats 
and pipets for the PCR, and another set for the agarose gel and DNA extraction but 
were stored in different places. All working spaces and pipets were wiped down with 




Master mixes: We purchased commercial PCR reagents (Invitrogen. Cat#12339-024, 
Grand Island, NY). Master mixes followed the methods of Barletta, et al (2009) with 
minor modification. Master mix A contained 10x AccuPrime PCR Buffer-1 with 
2.0mM MgCl2 (final 3.5mM MgCl2) and 0.4 M of the forward and reverse primers. 
Master mix B contained 19 µL of the Master mix A with 1µL of AccuPrime Taq 
polymerase. We made sufficient amounts of the Master mixes for a second round of 
PCR and preloaded the PCR tubes for the second round and closed the caps in Lab-1 
at the start of the experiment. We then carried closed the tubes for the second round 
of PCR until we reached Lab-3 and stored them at -20C in Lab-3 until the end of the 
first round of the PCR. All the Master mixes were prepared in Lab-1 prior to the start 
of the experiment to prevent any aerosol contamination during the sample loading, 
especially before the second round of PCR at the Lab-3, and to prevent carrying back 
of the product to Lab-1. 
We performed all PCR in the MyCycler Thermal cycler (Bio-rad, Hercules, CA). Our 
PCR amplification cycles were 1 x (95C for 30 s) for denaturing; 20 x for the first 
round and 50 x for the second round (95C for 30 s; 55C for 1 min, and 68C for 30 s), 
then 75C for 4 mins and maintains the reaction at 4C after the PCR cycling ends. 5µL 
of PCR-grade water or DNA template (total 5fg) were added to the sample for the 
first round of PCR. After the first round, we transferred 5µL of the first round PCR 
product to new PCR tubes, and ran second round of PCR. For example, 5µL of the 
Negative control-1 PCR products was transferred to a new Negative control-1 tube. 




agarose gels and observed the presence and locations of the bands on the agarose gel 
with DNA ladder (Bio-rad, #170-8202, Hercules, CA). 
Samples: Three different negative controls (Negative control-1, 2 and 3) and the No-
DNA Polymerase-control (NPC) were designed to detect contamination arising from 
several different sources. Negative controls contained all PCR materials but no DNA 
template. Instead of the template, the same amount of the PCR-grade water was 
added. Negative control-1, 2 and 3 have the same materials, but have different names 
because materials are added in different labs. We made each control in duplicate in 
Lab-1. We carried Negative controls-2 and 3 throughout the experiment in duplicate. 
For Negative control-1 and the Positive control, after the first round of PCR, we split 
each duplicate into four samples for the second round of PCR to give two sets of 
quadruplicates for a total of 8 replicates of Negative Control-1 and the Positive 
control. This provided additional material for DNA extraction and sequencing. We 
made all of the replicates on the same day. The experimental procedure is 
diagrammed in Figure i.  
Positive control: contains all PCR required materials. 20µL of the Master mix B was 
loaded in Lab-1, and the cap was closed. It was opened in Lab-2 where the template 
was added and cap was reclosed before it was transferred to Lab-3. There was no 
additional action performed until the second round of PCR. 
Negative control-1: This sample is same as our negative control for routine PCR. 
20µL of the Master mix B was loaded and the 5µL of PCR-grade water was added as 
a negative template control in Lab-1. The cap was closed and no more action was 




Negative control-2: This sample was designed to test if environmental contamination 
occurs during the sample transfer from Lab-1 to Lab-2 and during the template 
adding. After 20µL of the Master mix B was loaded in Lab-1, we kept its cap open 
until the 5µL of PCR-grade water was added as a template in Lab-2. In Lab-2, the 
Negative control-2 was handled last and its cap closed after the Positive control was 
loaded with template. 
Negative control-3: This sample was designed to test if aerosol contamination 
occurred during the transfer between the first and second rounds of PCR products. 
20µL of the Master mix B were loaded and the 5µL of PCR-grade water that was 
added as a template in Lab-1. Then the cap was kept closed. We did not open it after 
the first round of PCR, and ran second round of PCR without transferring any PCR 
products.  
NPC: This sample was designed to confirm the primers do not produce any major 
PCR products without the Taq DNA polymerase. 19µL of the Master mix A, and 1µL 
of PCR-grade water was added instead of the DNA polymerase in Lab-1. Then, 5µL 
of the DNA template added in the Lab-2. 
 
Work-flow and PCR program: This experiment started in Lab-1 and moved to Lab-2 
and then into Lab-3 without going back into earlier labs on the same day to prevent 
any cross contamination. The detailed steps are shown in Figure i. 




1. Made Master mix A and B; 
2. Added Master mixes to the PCR tubes for the first and second rounds of 
PCR, and closed all caps except for Negative control-2 first round PCR tubes;  
3. Added PCR-grade water as a template in the following order: Negative 
control-1 and Negative control-3, then closed the caps; 
4. Added additional PCR-grade water to the NPC instead of the DNA 
polymerase, and closed the cap. 
In Lab-2, we performed following steps: 
1. Added a template in the following order: Positive control and NPC, and 
then closed the caps; 
2. Added the PCR-grade water as a template to the Negative control 2, and 
then closed the cap. 
In Lab-3, we performed following steps: 
1. Ran first round of the PCR (20 cycles); 
2. Transfer 5 l of the first round of the PCR product to the new tubes. The 
transferring order was as following: Negative control-1, Positive control, 
NPC, Negative control-2; 
3. Ran second round of the PCR (50 cycles); 




5. Gel purified DNAs (Positive control and Negative control-1); 
6. Sent the purified DNAs for sequencing. 






After we checked the bands of the second round PCR products on agarose gels, we 
gel purified DNA from the Positive control and Negative control-1s. We sequenced 
these DNAs to identify which DNA sequences were amplified in the bands. We sent 
DNAs to the Institute for Bioscience & Biotechnology Research (IBBR) at University 
of Maryland. The IBBR used an Applied Biosystems DNA sequencer (model 3730) 
and BigDye Terminator v3.1 Cycle Sequencing Kit for DNA sequencing. 




Chapter 3: Result 
We performed the pUC19 experiment once. We repeated the full experiment twice 
with Lambda, and repeated four more times for the Positive control and Negative 
control-1. 
pUC19 
The second round of the PCR product on agarose gel (Figure ii) was smeared from 
one set of quadruplicates the pUC19 Negative control-1 (set A) and the NPC showed 
no product. However, we observed bands from all replicates of the other controls: 
pUC19 Positive control, Negative control-1 (set B), Negative control-2, and Negative 
control-3. All of the bands were located at very similar locations (Figure ii). We 
observed that all bands were located slightly lower than 200 base pair band of the 
ladder as we expected for the 179 base pairs pUC19 product. 
Figure ii. 1% Agarose gel with second round PCR product from the pUC19 Positive 
control, Negative control (1, 2, and 3), and No DNA-Polymerase (NPC) control 
  
Description (Left (1) to right (24) Well):  
Well 1-4: pUC19 Positive control set A 
Well 5: blank 
Well 6-9: pUC19 Positive control set B 
Well 10: blank 




Well 15-18: pUC19 Negative control-1 set B 
Well 19-20: pUC19 Negative control-2 A, B 
Well 21-22: pUC19 Negative control-3 A, B 
Well 23-24: pUC19 NPC control A, B 
Well 25: DNA ladder 
 
We gel purified DNAs from the Positive controls and Negative control-1, confirmed 
purified DNAs had a clean and single band (Figure iii), and then sent them for DNA 
sequencing. After we obtained the DNA sequences, we aligned the pUC19 plasmid 
vector DNA (Genbank Accession number #L09137.2), the Positive control extracted 
DNA and the Negative control-1 extracted DNA using the ClustalW, and found that 
over 130 base pairs are quite similar, and base pairs near 3’ are not really close 
(Figure iv). However, when we did BLAST the Positive control and the Negative 
control-1, we found they are more closely matched to varieties of cloning vectors 
(Table i)  
Figure iii. Extracted DNAs from the pUC19 and Lambda Positive control and 
Negative control-1 on 1% Agarose gel run 
 
Description (Well left (1) to right (12)): 
Well 1: DNA extracted from the pUC19 Positive control  
Well 2: DNA extracted from the pUC19 Negative control-1 Set B (well 6-9 on 
the Figure ii) 
Well 3: Ladder 
Well 4: DNA extracted from the Lambda Positive control 
Well 5: Blank 
Well 6-11: DNAs extracted from the Lambda Negative control-1. 





Figure iv. ClustalW DNA alignment of the pUC19 plasmid vector DNA (Ref), 
extracted DNA from the pUC19 Positive control (Positive-pUC19), and extracted 





Table i. pUC19 BLAST result from the pUC19 Positive control and Negative control-
1 extracted DNA (Some matched BLAST results) 
 




Positive control Cloning vector pNHG, 
complete sequence 
JQ585717.1 98 
Plasmid vector pFKm4, 
complete sequence 
JX504717.1 98 
Plasmid vector pEXGm5B, 
complete sequence 
JX504716.1 98 
Allelic replacement vector 
pAMG270, complete sequence 
JX477172.1 98 
Gateway recycling vector 
pCON-R5R6 DNA, complete 
sequence 
AB752387.1 98 
Negative control-1 Cloning vector pME-lama4-
NS, complete sequence 
JX217820.1 99 
Cloning vector p5E-twhh, 
complete sequence 
JX261972.1 99 
Cloning vector pME-ILK-NS, 
complete sequence 
JX261971.1 99 
Plasmid vector pFKm4, 
complete sequence 
JX504717.1 99 
Gateway recycling vector 








After we ran the second round of PCR products on the agarose gel, we observed no 
bands from the NPC (Figure v). However, compared to the pUC19, Lambda controls 
showed strange results. The Positive controls showed strong bands and their locations 
seemed correct (Figure v). The Positive control bands were located slightly above the 
200 base pair band of the ladder as we expected for the 218 base pairs for Lambda 
product. However, Negative controls showed inconsistent results. The Lambda 
Negative control-1 set A showed bands at about 600 or 700 base pairs, while the 
Negative control-1 set B did not show any bands. Neither set of Negative control-2 
showed bands. One of the Negative control-3 set showed two bands, while the other 
Negative control-3 had very weak bands at another location. No lambda Negative 
controls produced bands that migrated the same distance as the Positive control. 
Because of the inconsistent results, we repeated the Lambda experiment (data not 
show), and observed consistent results for the Positive control but inconsistent result 
for the Negative controls once again. Because of the inconsistent results, we repeated 
the Lambda experiment several times for the Positive control and Negative control-1. 
We continuously observed consistent results from the Positive control, but 






Figure v. 1% Agarose gel with second round PCR product from the Lambda Positive 
control, Negative control (1, 2, and 3), and No DNA-Polymerase Control (NPC) 
 
Description (Left (1) to right (24) Well): 
Well 1-4: Lambda Positive control set A 
Well 5-8: Lambda Positive control set B 
Well 9: Blank 
Well 10-13: Lambda Negative control-1 set A 
Well 14-17: Lambda Negative control-1 set B 
Well 18: Blank 
Well 19-20: Lambda Negative control-2 A, B 
Well 21-22: Lambda Negative control-3 A, B 
Well 23-24: Lambda NPC control A, B 
Well 25: DNA Ladder 
Because we performed multiple experiments for the Positive control and the Negative 
control-1, we gel purified 2 DNAs from the Positive control and multiple DNAs from 
the Negative controls. After we confirmed all the purified DNA had a clean and 
single band (Figure iii), we sent all of them (2 Positive control DNAs, 6 Negative 
control-1 DNAs) for DNA sequencing. Through the BLAST, we found that both of 
the extracted Positive control DNAs were matched (99% for one and 98% for 
another) to the Enterobacteria phage lambda, a complete genome (GenBank accession 
number: J02459.1) (Data not shown). We found that the extracted DNAs from the 
Negative control-1 had a very different result. We tested all of the Negative control 
sequences, and found many of them matched the broad ranges of BAC (Bacterial 
artificial chromosome) clones; One of the Negative control sequences matched the 




DNAs were matched to the Lambda phage DNA. We aligned the Negative control-1 
DNAs, Positive control, and the Lambda phage DNA by the ClustalW. Some 
extracted Lambda Negative control-1 DNAs showed some similarity to the Lambda 
phage DNA and the Lambda Positive control (Figure vi). 
 
Table ii. Lambda BLAST result from the Lambda Positive control and multiple 
Negative control-1 extracted DNAs (Some matched BLAST results) 




Negative control-1  
(well 6 on figure 
iii) 
Homo sapiens BAC clone 
RP11-327N17 from 2, 
complete sequence 
AC007041.3 97 
Pan troglodytes BAC clone 
CH251-29B11 from 
chromosome 7, complete 
sequence 
AC198714.4 91 
Negative control-1  
(well 7 on figure 
iii) 
Homo sapiens 3 BAC RP11-
234A1 (Roswell Park Cancer 
Institute Human BAC Library) 
complete sequence 
AC073861.29 100 





Negative control-1  
(well 8 on figure 
iii) 
Homo sapiens chromosome X 
sequence from BAC 
CEPHB197N14 region 
PHKA1-DXS227 map Xq13, 
complete sequence 
AL135749.3 98 
Homo sapiens BAC clone 
CTD-2007N20 from 
chromosome 2, complete 
sequence 
AC145029.2 98 
Negative control-1  
(well 9 on figure 
iii) 




TypeIA2 P.acn33, complete 
genome 
CP003195.1 99 
Negative control-1  
(well 10 on figure 
iii) 
Human DNA sequence from 
clone RP3-340G1 on 






Negative control-1  
(well 11 on figure 
iii) 
Pan troglodytes BAC clone 
CH251-329N17 from 
chromosome 7, complete  
sequence 
AC211562.4 100 
Human chromosome 14 DNA 
sequence BAC C-2509G16 of 
library CalTech-D from 
chromosome 14 of Homo 




Figure vi. ClustalW Alignment of the Lambda phage DNA (Ref), extracted DNA 
from the Lambda Positive control (Positive-Lambda), and DNA extracted from the 





Chapter 4: Discussion 
We observed that both the pUC19 and Lambda Positive controls’ from the second 
round of PCR products gave off strong bands in the right location. We designed the 
different Negative controls to test where the contamination came from. If we observe 
the bands from the Negative control-1 and 2, then it would indicate that the 
contamination came from the Lab-3. If we observe the bands from the Negative 
control-2 only, then would indicate that the contamination came from the Lab-2. If 
we observe the bands from all three of the Negative controls, then it would indicate 
either the contamination came from the Lab-1 or from the PCR reagent itself. 
However, the contamination of the Lab-1 had a low probability. Because A) we 
designed new primers that were not overlapped to the previously made PCR products 
or previously used primers to prevent contamination: B) we cleaned the entire  
working area in the Lab-1 with bleach (10% v/v): C) we have never put neither the 
previous nor new PCR products back to the Lab-1. Because the probability of 
contamination from Lab-1 is very low, PCR reagent - especially Taq DNA 
polymerase - was highly suspected as a contamination source. 
 
pUC19 
From the agarose gel experiment, we observed smear bands from the Negative 
control-1 of set A through two rounds of PCR. Over the course of numerous PCR 




negative control that had smeared gels and no bands, so an experimental error cannot 
be ruled out. The smeared Negative control-1 of set A would be the weakness of the 
study. Except for the Negative control-1 of Set A, we observed bands from the 
pUC19 Negative control-1 of set B, 2, and 3, and observed strong bands in the same 
locations as the pUC19 Positive control. We observed bands from all Negative 
controls, except Negative control-1 of Set A, and it indicates contamination would 
have come from Lab-1. In particular, the amplification of both replicates of Negative 
control-3 strongly supported that the contamination was not from the environment in 
Labs-2 and 3 but came from Lab-1. We have never put PCR products back into the 
Lab-1. In addition, we have never stored or used pUC19 complete DNA in the Lab-1. 
These support contamination of the Lab-1 has low a probability and the 
contamination would have come from the PCR reagent, especially Taq DNA 
polymerase itself. 
We identified which DNA fragment was amplified from the Negative control-1. We 
found that the pUC19 plasmid vectors completed DNA, the extracted pUC19 Positive 
control DNA, and the extracted pUC19 Negative control-1 DNA had very close DNA 
sequences. However, although both the Positive control and Negative control 
sequences were very close to the pUC19 complete sequence, we found they did not 
match to the pUC19 sequence through the BLAST. We aligned the Positive control’s 
and the Negative control’s sequences to the pUC19 complete sequence, and found 
that both of the control sequences were aligned to the region that overlaps to the 
origin of replication on the pUC19. A high portion of the pUC19 complete sequences, 




that the both the Positive control and Negative control-1 were matched to a variety of 
sequences and cloning vectors, and most of them contained an origin of the 
replication from pBR322 or pUC (Data not shown). Any sequences or cloning vectors 
that contained the origin of replication from either the pBR322 or pUC were very 
close. This would occur because the pUC19 primer binds sequences that other 
cloning vectors shared rather that binding within a pUC19 specific sequence. 
  
All of these results strongly support that contamination can come from the Taq DNA 
polymerase, the Taq DNA polymerase contains pUC related residual DNA, and our 
primers can bind and amplify without the template. 
 
Lambda 
We repeated the full experiment twice, and observed bands from one set of the 
Negative control-1 and both of Negativecontrol-3 from one experiment (Figure v), 
and observed bands from all Negative controls, except for one of the Negative 
control-2 set from the other experiment (Data not shown). Both experiments provided 
inconsistent results in terms of the presence and the location of the bands from the 
Lambda Negative controls’ second round of PCR products. Not all of the Lambda 
Negative controls showed bands. This could be possible considering that no bands of 
Negative controls indicate the detection of environmental contamination. However, 
we observed this phenomenon from the previous Real-Time PCR test. From our 
previous PCR test, our Lambda Negative controls were occasionally amplified and 




be related to the Limit of Detection (LOD). Real-time PCR’s LOD is at least 100 
folds more sensitive than that of the agarose gels’. Occasionally, we observed strange 
shapes of an amplification curve that had have very low amounts of amplification 
from the previous Real-time PCR. If a very low number of DNA copies were to be 
amplified, it would not have been detected or visualized on the agarose gel. Thus, it is 
possible that the Lambda Negative control was amplified but not observed on the 
agarose gel because the amounts of PCR products were lower than that of the agarose 
gel’s LOD. 
A different location of the Lambda Negative control bands can also occur because of 
non-specific amplification. Compared to the pUC19 plasmid vector DNA, the 
Lambda phage DNA was much larger, and would have more of a chance of non-
specific binding. It is also possible that the new designed Lambda primers were not as 
specific as the primers used in Barletta et al (2009). If we had used the better 
designed primers, it may have reduced the detection of non-specific PCR products. 
However, we cannot guarantee that the probe would have been able to distinguish 
non-specific PCR products. From our previous Real-Time PCR, we observed 
amplification even though we used probe. Some of the Lambda Negative control had 
regions that were similar to the Lambda phage DNA and Lambda Positive control 
(figure vi). If we designed the primers and the probe was able to bind to certain 
similar regions, we would have obtained false information. 
 
We tested all the extracted Lambda Negative control-1 DNAs through the BLAST, 




another sequence was matched to the bacterial genome. Due to the fact that the 
Lambda Negative control sequences are similar to very broad ranges of sequences, it 
is hard to conclude which sequences the Negative control matched.  
Compared to the pUC19, the Lambda results did not strongly support the Taq DNA 
polymerase which contained the Lambda phage like DNA. However, this strongly 
supports that the Taq DNA polymerase would contain some residual DNAs that could 
be amplified by the Lambda primers without the template. 
 
Conclusion 
Taq DNA polymerase is an enzyme found in the Thermuc aquaticus bacterium. We 
contacted a company where we bought the Taq DNA polymerase system, but we 
could not obtain detailed information about how the company manufactured the Taq 
DNA polymerase system. It is likely that the Thermus aquaticus gene is cloned and 
expresses its protein in the Eschericia coli, and then the protein is extracted and 
stabilized with animal protein. Because of this, it is possible that the Taq DNA 
polymerase contains some residual DNA and pUC19 and Lambda primers could bind 
to some of the residual DNA in the Taq DNA polymerase or anything in the Taq 
DNA polymerase system, and could amplify without the template. We demonstrated 
that the commercial Taq DNA polymerase system would contain some residual DNA 
that were very similar to the pUC19 plasmid vector DNA, and DNA that could be 
amplified by the Lambda primers without the template. We only tested the pUC19 




DNA polymerase system could contain other types of DNA as well. Therefore, it is 
highly recommended to test DNA polymerase if it contained any residual DNA 
before using the PCR tests. Although the false positive problem associated with the 
PCR reagent has been reported related to the PCR, there was no literature on iqPCR 
that discussed this issue. False positive DNA amplification in the iqPCR was not 
observed because other conventional PCR was usually not run in two rounds with a 
total of 70 cycles. Previously, in our Real-Time PCR with 50 cycles (1 round), neither 
the pUC19 nor the Lambda Negative controls ever detected amplification (Data is not 
shown). However, if an additional round of PCR was added, we almost always 
observed amplification of negative control. This implies that amounts of the residual 
DNA in the Taq polymerase would be very minimal and would not induce significant 
problems if the PCR ran only 50 or less cycles. If a very small amount of DNA 
amplification is observed because of contamination from manufacturing, it has a high 
probability that environment contamination is suspect. Thus, it is highly 
recommended to test their PCR reagent if it contains any residual DNA at the 
beginning, especially for a very sensitive iqPCR assay, or use of decontamination 
techniques to remove residual DNA. 
 
Limitation 
The Lambda DNA experiment did not demonstrate that the extracted Lambda 
Negative control DNAs matched that of the Lambda phage DNA. Although it has 
been proved that the Taq DNA polymerase contains some residual DNA that can be 




DNA is in the Taq DNA polymerase. Better designed primers or improvement of the 
PCR condition could reduce the non-specific amplification. However, we cannot 
guarantee this because we tried to improve our PCR condition without success from 
the previous PCR experiment. Therefore a better decontamination technique would be 
the best method to solve this problem. 
 
Although we used commercial PCR-grade water for this experiment, it is not a 
guarantee that the PCR-grade water was really contamination free. Even 
commercially purified water that was used for the PCR produced false positive 
results, and recommended autoclave the commercial PCR-grade water
20
. Thus, it 
would be preferred to use autoclaved PCR-grade water to eliminate the possibility of 
contamination from PCR-grade water. Commercial PCR reagents contain PCR 
materials in addition to the Taq DNA polymerase. The Taq DNA polymerase is 
highly suspected as contamination source. However, other PCR reagents, such as 
provided buffer - AccuPrime PCR Buffer-1, would be a contamination source. 
 
Future Application as public health perspective 
  
Many times, the amount of environmental factors or biomarkers is very minimal, and 
requires a very sensitive technique to detect. We wanted to develop iqPCR for the 
detection of cytokines, as a biomarker, from exhaled breath. The amount of cytokines 
in exhaled breath is very low, and iqPCR would be very useful. Because iqPCR is 
very sensitive, contamination would fail the proper performance of an assay. 




contamination through multiple strategies. However, contamination can come from 
PCR reagents itself, thus it is highly recommended to test PCR at the beginning if it 







Appendix A: Previously used and new primer sequences            
 
Previous primer sequences: 
 
Previous pUC19 primers (Designed in cooperate research lab, Dr, Ian White’s 
research lab at UMCP) 
Forward: 5’-Biot / TCC GAC CCT GCC GCT TAC -3’ 
Reverse Primer: 5’-GAC CTA CAC CGA ACT GAG ATA CC-3’ 
 
Previous Lambda Primers (Same primers used in Barletta, et al (2009) paper. 
Forward: 5’-GGA TGA ACC TGT GGC ATT TGT GCT-3’ 
Reverse: 5’-GCC ATG TAC CCG CGT ATC GTT TCA-3’ 
 
New primer sequences: 
New primer sequence for pUC19 (expected PCR products: 179 base pairs):  
Forward: 5’-CTG CGC TCT GCT GAA GCC AGT TAC C-3’ 
Reverse: 5’-CGT TCC ACT GAG CGT CAG ACC CCG T -3 
 
New primer sequence for Lambda (expected PCR product: 218 base pairs) 
Forward: 5’-AGC TTG CAT CCA TTG CAT CGC TTG A-3’ 
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